CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Impact of Artificial Intelligence in Synthetic Biology

Impact of Artificial Intelligence in...

The Prospect of Synthetic Biology in Altering the Life Science Sector

The Prospect of Synthetic Biology in...

Key Applications of Synthetic Biotechnology

Key Applications of Synthetic...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

Impact of Artificial Intelligence in Synthetic Biology

Impact of Artificial Intelligence in...

The Prospect of Synthetic Biology in Altering the Life Science Sector

The Prospect of Synthetic Biology in...

Key Applications of Synthetic Biotechnology

Key Applications of Synthetic...

Achieving trial master file quality, timeliness and completeness

Achieving trial master file quality,...

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

The Dynamic Commercial Aspects of Life Sciences

The Dynamic Commercial Aspects of...

The Future of Life Sciences Industry

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Accelerating Digital Transformation...

It's Time to Embrace Synthetic Biology

Life Sciences Review | Tuesday, July 12, 2022
Tweet

Companies developing synthetic biology solutions are redesigning conventional manufacturing procedures to create new, more environmentally friendly methods to produce them.


FREMONT, CA: Synthetic biology has emerged as a disruptive force that is giving rise to the bio-economy. It offers new ways to produce nearly everything humans consume, from flavors and fabrics to foods and fuels. Microorganisms can make many of the things that industrial processes currently manufacture. Raw material supply may no longer be a limiting factor for supply.


Synthetic Biology is changing products and manufacturing processes


Biologists have drawn on molecular, cell, and systems biology advancements to convert the science from an analytical to an engineering field, much of how synthesis transformed chemistry and chip design changed computing in the last century. Hardware engineers use the physical qualities of materials to create new integrated circuits and microprocessors. Still, biologists can create synthetic biology systems that assist businesses in changing their products, processes, or both.


Develop fresh products and procedures


Many start-up synthetic biology companies have created entirely new products that use less natural resources to manufacture than the ones they replace. 


Due to the items' higher sustainability and ability to be tailored to each application or customer, the competitors can sell them for higher prices.


Boost the efficiency of current products or procedures


Many synthetic biology companies are redesigning conventional manufacturing procedures and creating new, more environmentally friendly methods of producing well-known goods than the ones currently in use. They frequently depend on petrochemicals, derivatives, or other environmentally hazardous chemicals. Cell-based procedures also increase production since they allow for the engineering of microorganism strains that will produce the highest yields.


Reduce the price or make more of the scarce raw materials available


Similar to how brewers and pharmaceutical businesses utilize vats of yeast to generate beer and insulin, synthetic biology companies routinely manufacture products by fermenting plant-based feedstock. No particular raw materials are required for the process, and some plant-based feedstocks are produced at scale for less money.


Weekly Brief

loading
Top 10 Synthetic Biology Companies - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/it-s-time-to-embrace-synthetic-biology-nwid-888.html